Logo image of INLX

INTELLINETICS INC (INLX) Stock Fundamental Analysis

USA - NYSEARCA:INLX - US45825X2045 - Common Stock

12.38 USD
-0.06 (-0.48%)
Last: 9/16/2025, 10:33:20 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to INLX. INLX was compared to 280 industry peers in the Software industry. While INLX seems to be doing ok healthwise, there are quite some concerns on its profitability. INLX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

INLX had negative earnings in the past year.
INLX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INLX reported negative net income in multiple years.
INLX had a positive operating cash flow in each of the past 5 years.
INLX Yearly Net Income VS EBIT VS OCF VS FCFINLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

The Return On Assets of INLX (-6.12%) is comparable to the rest of the industry.
The Return On Equity of INLX (-10.61%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.12%
ROE -10.61%
ROIC N/A
ROA(3y)-0.03%
ROA(5y)-2%
ROE(3y)0.16%
ROE(5y)-27.83%
ROIC(3y)N/A
ROIC(5y)N/A
INLX Yearly ROA, ROE, ROICINLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

INLX has a Gross Margin (64.73%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of INLX has declined.
The Profit Margin and Operating Margin are not available for INLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y-3.79%
INLX Yearly Profit, Operating, Gross MarginsINLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

INLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, INLX has more shares outstanding
INLX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for INLX has been reduced compared to a year ago.
INLX Yearly Shares OutstandingINLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
INLX Yearly Total Debt VS Total AssetsINLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

INLX has an Altman-Z score of 3.40. This indicates that INLX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.40, INLX is in line with its industry, outperforming 59.64% of the companies in the same industry.
INLX has a debt to FCF ratio of 0.70. This is a very positive value and a sign of high solvency as it would only need 0.70 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 0.70, INLX is doing good in the industry, outperforming 76.43% of the companies in the same industry.
INLX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
INLX has a better Debt to Equity ratio (0.02) than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.7
Altman-Z 3.4
ROIC/WACCN/A
WACC11.13%
INLX Yearly LT Debt VS Equity VS FCFINLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

INLX has a Current Ratio of 0.79. This is a bad value and indicates that INLX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of INLX (0.79) is worse than 80.71% of its industry peers.
A Quick Ratio of 0.78 indicates that INLX may have some problems paying its short term obligations.
INLX's Quick ratio of 0.78 is on the low side compared to the rest of the industry. INLX is outperformed by 81.07% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.78
INLX Yearly Current Assets VS Current LiabilitesINLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for INLX have decreased strongly by -1100.00% in the last year.
The Revenue has been growing slightly by 6.70% in the past year.
The Revenue has been growing by 48.02% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-750%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y16.28%
Revenue growth 5Y48.02%
Sales Q2Q%-13.59%

3.2 Future

INLX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -54.27% yearly.
Based on estimates for the next years, INLX will show a small growth in Revenue. The Revenue will grow by 4.13% on average per year.
EPS Next Y-325%
EPS Next 2Y-54.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.04%
Revenue Next 2Y4.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
INLX Yearly Revenue VS EstimatesINLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
INLX Yearly EPS VS EstimatesINLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INLX. In the last year negative earnings were reported.
Also next year INLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INLX Price Earnings VS Forward Price EarningsINLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

INLX's Enterprise Value to EBITDA ratio is in line with the industry average.
76.07% of the companies in the same industry are more expensive than INLX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.07
EV/EBITDA 125.83
INLX Per share dataINLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as INLX's earnings are expected to decrease with -54.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-54.27%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INLX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTELLINETICS INC

NYSEARCA:INLX (9/16/2025, 10:33:20 AM)

12.38

-0.06 (-0.48%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners4.38%
Inst Owner Change78.45%
Ins Owners26.31%
Ins Owner Change0.92%
Market Cap55.46M
Analysts82.86
Price Target14.79 (19.47%)
Short Float %0.03%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.28%
Min EPS beat(2)-85.19%
Max EPS beat(2)87.75%
EPS beat(4)1
Avg EPS beat(4)-257.69%
Min EPS beat(4)-982.35%
Max EPS beat(4)87.75%
EPS beat(8)2
Avg EPS beat(8)-160.46%
EPS beat(12)6
Avg EPS beat(12)-30.67%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.31%
Min Revenue beat(2)-6.54%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.97%
Min Revenue beat(4)-6.54%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-1.35%
Revenue beat(12)6
Avg Revenue beat(12)0.34%
Revenue beat(16)9
Avg Revenue beat(16)0.96%
PT rev (1m)-12.12%
PT rev (3m)-17.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-45.45%
EPS NY rev (1m)-31.58%
EPS NY rev (3m)-31.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.89%
Revenue NY rev (1m)-5.9%
Revenue NY rev (3m)-10.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.12
P/FCF 25.07
P/OCF 17.69
P/B 5.35
P/tB 88.46
EV/EBITDA 125.83
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)0.49
FCFY3.99%
OCF(TTM)0.7
OCFY5.65%
SpS3.96
BVpS2.31
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.12%
ROE -10.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.73%
FCFM 12.46%
ROA(3y)-0.03%
ROA(5y)-2%
ROE(3y)0.16%
ROE(5y)-27.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y-3.79%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.7
Debt/EBITDA 0.38
Cap/Depr 73.21%
Cap/Sales 5.2%
Interest Coverage N/A
Cash Conversion 715.66%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.78
Altman-Z 3.4
F-Score5
WACC11.13%
ROIC/WACCN/A
Cap/Depr(3y)67.37%
Cap/Depr(5y)74.13%
Cap/Sales(3y)3.99%
Cap/Sales(5y)3.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-750%
EPS Next Y-325%
EPS Next 2Y-54.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.7%
Revenue growth 3Y16.28%
Revenue growth 5Y48.02%
Sales Q2Q%-13.59%
Revenue Next Year-5.04%
Revenue Next 2Y4.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-204.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year651.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y224.19%
FCF growth 3Y55.92%
FCF growth 5YN/A
OCF growth 1Y134.35%
OCF growth 3Y40.54%
OCF growth 5YN/A